---
created: 2025-04-13
updated: 2025-04-13T10:52
id: h!i~u|ghj=
specialty: pharmaco
specialty_id: 200
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::05-cardio::08-hypertension::03-antihypertensives
  - "source/ak-step1-v11:": 
  - theme/firstaid::05-pharmacology::02-autonomic-drugs::14-b-blockers
  - "source/ak-step1-v11:": 
  - theme/firstaid::05-pharmacology::02-autonomic-drugs::14-b-blockers::*basics
  - "source/ak-step1-v11:": 
  - source/ome-banner::clinical::01-cardiology::08-hypertension
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::01-autonomic-drugs::02-sympathetic::04-beta-blockers
  - "source/ak-step1-v11:": 
  - theme/uworld::1000-9999::1000-1999::1492
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield"
type: flashcard
---

# Question
Are Î²-blockers contraindicated in diabetic patients?    **No**

---

# Answer
despite theoretical concern of masking hypoglycemia, benefits outweigh the risks